Matthew O'Brien (Piper Sandler) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Matthew O'Brien's stock ratings?

About 50% of Matthew's ratings were profitable over a one-year hold, with an average return of -0.9% per rating, measured by 13Foresight from historical prices.

Q: How is Matthew ranked?

Matthew O'Brien is ranked #2219 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Matthew O'Brien

PIPR

Matthew O'Brien

Piper Sandler

Wall Street Analyst

★★☆☆☆

#2219

on 13Foresight · ranked by our own returns

50%

Success Rate

-0.9%

Average Return

30 of 60 calls profitable · -8.7% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 50% of Matthew O'Brien's ratings turned a profit when each position was held for 1 year — averaging -0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

107 Buy 28 Hold 0 Sell

Matthew's Stock Coverage 55 ratings · 2026-06-19

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
MDT Medtronic	Jun 17, 2026	HOLD	Buy +23.7% avg upside 38 analysts	$85.00 7.13% Upside	+1.5%
GMED Globus Medical	Jun 15, 2026	BUY	Strong Buy +22.3% avg upside 24 analysts	$100.00 26.25% Upside	·
PODD Insulet	Jun 15, 2026	BUY	Strong Buy +79.3% avg upside 32 analysts	$210.00 44.02% Upside	·
DXCM Dexcom	Jun 15, 2026	BUY	Strong Buy +38.8% avg upside 32 analysts	$88.00 21.34% Upside	-1.4%
BSX Boston Scientific	Jun 12, 2026	BUY	Strong Buy +73.0% avg upside 38 analysts	$65.00 43.44% Upside	-3.4%
HTFL HeartFlow, Inc.	Jun 11, 2026	BUY	Strong Buy +9.2% avg upside 8 analysts	$38.00 13.02% Upside	+0.0%
MMED MiniMed Group, Inc.	Jun 04, 2026	HOLD	Strong Buy +48.5% avg upside 13 analysts	$16.00 8.41% Upside	·
CARL Carlsmed, Inc.	Jun 03, 2026	BUY	Strong Buy +83.2% avg upside 5 analysts	$18.00 78.74% Upside	·
TMDX TransMedics Group	Jun 02, 2026	HOLD	Strong Buy +53.4% avg upside 15 analysts	$63.00 19.97% Downside	+7.5%
BBNX Beta Bionics, Inc.	May 22, 2026	BUY	Strong Buy +53.1% avg upside 13 analysts	$20.00 44.14% Upside	+22.9%
SI Shoulder Innovations, Inc.	May 14, 2026	BUY	Strong Buy +14.2% avg upside 5 analysts	$19.00 2.38% Upside	+22.4%
TELA TELA Bio	May 13, 2026	HOLD	Strong Buy +1010.3% avg upside 8 analysts	$1.00 24.90% Upside	+3.1%
OBIO Orchestra BioMed Holdings	May 13, 2026	BUY	Strong Buy +234.3% avg upside 9 analysts	$9.00 125.47% Upside	+1.2%
CVRX CVRx	May 12, 2026	BUY	Strong Buy +136.7% avg upside 9 analysts	$12.00 142.52% Upside	+15.9%
KMTS Kestra Medical Technologies Ltd.	May 11, 2026	BUY	Strong Buy +37.5% avg upside 7 analysts	$30.00 50.49% Upside	-5.5%
TNDM Tandem Diabetes Care	May 08, 2026	BUY	Buy +115.3% avg upside 29 analysts	$33.00 115.70% Upside	+9.2%
ATRC Atricure	May 06, 2026	BUY	Strong Buy +59.3% avg upside 12 analysts	$50.00 73.61% Upside	+0.4%
ATEC Alphatec Holdings	May 06, 2026	BUY	Strong Buy +116.6% avg upside 22 analysts	$14.00 59.01% Upside	+15.7%
SYK Stryker	May 01, 2026	BUY	Strong Buy +24.1% avg upside 36 analysts	$420.00 36.47% Upside	+3.0%
KIDS OrthoPediatrics	May 01, 2026	BUY	Strong Buy +60.6% avg upside 10 analysts	$22.00 16.66% Upside	+14.0%
ITGR Integer Holdings	May 01, 2026	BUY	Buy +6.6% avg upside 15 analysts	$97.00 6.74% Upside	+7.6%
PRCT PROCEPT BioRobotics	Apr 30, 2026	BUY	Buy +81.6% avg upside 16 analysts	$35.00 61.12% Upside	-7.0%
CNMD Conmed	Apr 30, 2026	HOLD	Hold +81.5% avg upside 12 analysts	$39.00 19.61% Upside	-0.9%
ADGM Adagio Medical Holdings	Apr 14, 2026	BUY	Strong Buy +392.6% avg upside 2 analysts	$3.00 341.10% Upside	-57.0%
SIBN SI-Bone	Mar 23, 2026	BUY	Strong Buy +60.9% avg upside 18 analysts	$25.00 57.83% Upside	+9.0%
PEN Penumbra	Jan 15, 2026	HOLD	Buy +4.5% avg upside 23 analysts	$374.00 17.99% Upside	-9.4%
ZBH Zimmer Biomet Holdings	Oct 13, 2025	HOLD	Buy +27.6% avg upside 37 analysts	—	-6.2%
SGHT Sight Sciences	May 09, 2025	HOLD	Buy +54.1% avg upside 13 analysts	$3.50 33.67% Downside	+74.7%
STAA Staar Surgical	May 08, 2025	HOLD	Hold +14.3% avg upside 16 analysts	$16.00 45.05% Downside	+36.7%
TFX Teleflex	Feb 28, 2025	HOLD	Buy +42.3% avg upside 19 analysts	$140.00 10.33% Upside	-7.3%
RCEL Avita Medical	Feb 14, 2025	HOLD	Strong Buy +155.9% avg upside 10 analysts	$11.00 174.41% Upside	-60.6%
GKOS Glaukos	Jan 27, 2025	BUY	Strong Buy +5.9% avg upside 20 analysts	$180.00 37.79% Upside	-24.4%
APYX Apyx Medical	Aug 09, 2024	HOLD	Strong Buy +613.1% avg upside 10 analysts	$2.00 51.44% Downside	+109.6%
UTRS Minerva Surgical	Nov 14, 2023	BUY	Buy +799999900.0% avg upside 4 analysts	$3.00 299999900.05% Upside	·
HUMA Humacyte	Nov 10, 2023	HOLD	Strong Buy +654.7% avg upside 11 analysts	$3.00 224.48% Upside	+146.0%
IART Integra Lifesciences	Jun 26, 2023	HOLD	Buy +137.0% avg upside 21 analysts	$44.00 150.33% Upside	-29.2%
MOTS Motus Gi Holdings	Nov 14, 2022	BUY	Buy +49433233.3% avg upside 6 analysts	$90.00 89999899.92% Upside	·
ELUT Elutia	Nov 14, 2022	BUY	Strong Buy +666.0% avg upside 5 analysts	$10.50 890.52% Upside	-79.9%
STIM Neuronetics	Nov 09, 2021	BUY	Strong Buy +387.8% avg upside 6 analysts	$10.00 713.07% Upside	-27.7%
BAX Baxter International	Sep 02, 2021	HOLD	Hold +50.4% avg upside 23 analysts	$82.00 312.32% Upside	-29.5%
MMSI Merit Medical Systems	Jul 30, 2021	BUY	Strong Buy +36.1% avg upside 15 analysts	$79.00 17.49% Upside	-18.0%
TCMD Tactile Systems Technology	Jul 06, 2021	BUY	Strong Buy +55.5% avg upside 8 analysts	$70.00 162.97% Upside	-86.0%
KRMD REPRO-MED Systems	Mar 23, 2021	HOLD	Strong Buy +64.8% avg upside 9 analysts	$3.50 10.33% Downside	-22.9%
COO Cooper Co	Feb 11, 2021	BUY	Buy +102.5% avg upside 21 analysts	$435.00 559.92% Upside	+2.4%
VTAK Catheter Precision	Jan 27, 2021	HOLD	Buy +2677.9% avg upside 5 analysts	$7.00 733.42% Upside	-87.3%
LIVN LivaNova	Jan 12, 2021	BUY	Strong Buy +0.2% avg upside 14 analysts	$73.00 7.09% Downside	+25.4%
VRAYQ Viewray	Jan 12, 2021	BUY	Strong Buy +558333233.4% avg upside 12 analysts	$7.00 699999899.99% Upside	-11.3%
ALGN Align Tech	Jul 23, 2020	BUY	Strong Buy +58.0% avg upside 21 analysts	$345.00 89.44% Upside	+113.4%
ISRG Intuitive Surgical	Sep 25, 2019	BUY	Strong Buy +29.5% avg upside 36 analysts	$633.00 55.55% Upside	+23.6%
LFWD Lifeward	Jan 07, 2018	BUY	Strong Buy +5.3% avg upside 8 analysts	$3.00 56.65% Downside	-78.0%
MDXG MiMedx Group	Dec 13, 2017	BUY	Strong Buy +185.0% avg upside 17 analysts	$18.00 390.40% Upside	-85.7%
INGN Inogen	Nov 07, 2017	HOLD	Buy +285.2% avg upside 7 analysts	$96.00 1397.69% Upside	+53.3%
XRAY DENTSPLY SIRONA	Aug 09, 2017	BUY	Buy +171.7% avg upside 25 analysts	$69.00 567.94% Upside	-28.2%
RMD Resmed	Aug 02, 2017	HOLD	Buy +25.4% avg upside 27 analysts	$70.00 62.81% Downside	+52.2%
XTNT Xtant Medical Holdings	Aug 14, 2014	BUY	Strong Buy +1451.0% avg upside 9 analysts	—	-22.9%

🔒 50 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Matthew O'Brien — Frequently Asked Questions

How accurate are Matthew O'Brien's stock ratings?

Based on the calls 13Foresight could measure, about 50% of Matthew's ratings were profitable over a one-year hold, with an average return of -0.9% per rating, or -8.7% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Matthew ranked on 13Foresight?

Matthew O'Brien is currently ranked #2219 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Matthew cover?

Matthew most recently has ratings on MDT, GMED, PODD, DXCM, BSX, HTFL, MMED, CARL, TMDX, BBNX, SI, TELA and 43 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!